Generic

Semaglutide generics likely to widen access but raise dropout risks

Experts add that while the introduction of branded generics will trigger an acceleration in volumes for GLP-1 agonists, the value growth may moderate due to price erosion

Aurobindo arm launches Pomalidomide generic in US, adds to oncology line

Aurobindo Pharma subsidiary Eugia Pharma has launched generic Pomalidomide Capsules in the US, one of the first-to-file applicants for the drug, expanding its oncology portfolio

What are generic medicines and how India became the 'pharmacy of the world'

India is the world's largest producer and exporter of generic drugs. But how did it manage to do so? Let us find out here

Generic 2.0: A call for regulatory vigilance

Biosimilars have the potential to offer affordable treatment to many currently untreatable diseases but striking a balance between affordability and regulation will be crucial

Intense price competition in US generics market hits Indian pharma

Players say low prescription, double-digit price erosion are key reasons

Generic Engineering Construction bags construction orders worth Rs 81 cr

The company has been awarded with new work orders worth Rs 80.80 crore (including GST) for various institutional projects from new reputed clients

US-led growth helps Cadila post steady Q1 show even as India biz falters

While India business disappointed, lower expenses helped margins

Natco partner clears one patent hurdle for US generic launch

This is for the generic version of a popular drug for multiple sclerosis, Copaxone 40 mg